Spasticity, Muscle

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ipsen
IpsenChina - Tianjin
2 programs
Bedside Referral ToolN/A1 trial
Data collectionN/A1 trial
Active Trials
NCT03209960Completed60Est. Aug 2018
NCT03442660Completed104Est. Aug 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IpsenData collection
IpsenBedside Referral Tool

Clinical Trials (2)

Total enrollment: 164 patients across 2 trials

NCT03442660IpsenData collection

Validation of the Spasticity Related Quality of Life Questionnaire

Start: May 2018Est. completion: Aug 2019104 patients
N/ACompleted
NCT03209960IpsenBedside Referral Tool

Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity

Start: Jan 2018Est. completion: Aug 201860 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space